![Armen Shanafelt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Armen Shanafelt
President chez
Abshanafelt Advisory
Profil
Armen Shanafelt brings over 29 years of operational experience in the pharmaceutical, biotechnology, and diagnostic businesses to Lilly Ventures.
Previous to joining Lilly Ventures in 2009, Armen held leadership and executive positions in the R&D organizations of DNAX Research Institute, Bayer Pharmaceuticals, Roche Diagnostics, and Eli Lilly and Company.
Armen currently serves as a director on the boards of Aeglea BioTherapeutics (NASDAQ: AGLE), Aileron Therapeutics (NASDAQ: ALRN), Protagonist Therapeutics (NASDAQ: PTGX), Surface Oncology (NASDAQ: SURF), Sutro Biopharma and Symic Biomedical.
He is a Kauffman Fellow (Class 14).
Armen received his B.S.
Degree in Chemistry and Physics from Pacific Lutheran University, and his Ph.D.
in Chemistry from the University of California, Berkeley.
Postes actifs de Armen Shanafelt
| Sociétés | Poste | Début |
|---|---|---|
Abshanafelt Advisory | President | 01/01/2021 |
Anciens postes connus de Armen Shanafelt
| Sociétés | Poste | Fin |
|---|---|---|
| SURFACE ONCOLOGY, INC. | Directeur/Membre du Conseil | 08/09/2023 |
| SPYRE THERAPEUTICS, INC. | Président | 01/01/2019 |
LV Management Group, LLC
 LV Management Group, LLC Investment ManagersFinance Lilly Ventures invests in companies located in the European regions and North America, primarily in the United States. The firm target companies operating in the fields of life sciences, biotechnology, medical technology and healthcare information technology sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01/12/2020 |
| REIN THERAPEUTICS INC. | Directeur/Membre du Conseil | 19/06/2019 |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Directeur/Membre du Conseil | 01/06/2019 |
Formation de Armen Shanafelt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
17
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 17 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Bayer Corp.
 Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products | Health Technology |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
Rein Therapeutics, Inc.
 Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs | Health Technology |
Symic Bio, Inc.
 Symic Bio, Inc. BiotechnologyHealth Technology Develops new category of therapeutics | Health Technology |
Spyre Therapeutics, Inc.
 Spyre Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
Symic Holdings LLC
 Symic Holdings LLC BiotechnologyHealth Technology Develops new category of therapeutics | Health Technology |
Roche Diagnostics Corp.
 Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Develops and produces medical tests and digital tools | Health Technology |
LV Management Group, LLC
LV Management Group, LLC Investment ManagersFinance Lilly Ventures invests in companies located in the European regions and North America, primarily in the United States. The firm target companies operating in the fields of life sciences, biotechnology, medical technology and healthcare information technology sectors. It provides financing for early stage capital requirements. | Finance |
Pacific Lutheran University
 Pacific Lutheran University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HemaQuest Pharmaceuticals, Inc.
 HemaQuest Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics | Health Technology |
DNAX Research, Inc. | |
Protagonist Therapeutics, Inc.
 Protagonist Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures peptide based therapeutic products | Health Technology |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Abshanafelt Advisory |
